GreenSky Capital

Type

Venture Capital

Status

Active

Location

Toronto, Canada

Total investments

48

Average round size

2M

Portfolio companies

29

Rounds per year

3.00

Lead investments

17

Follow on index

0.40

Exits

3

Stages of investment
Seed
Areas of investment
BiotechnologySoftwareFinTechInformation TechnologyArtificial IntelligenceHealth CareSaaSMedicalPharmaceuticalGreenTech

Summary

GreenSky Capital appeared to be the VC, which was created in 2008. The company was established in North America in Canada. The main office of represented VC is situated in the Toronto.

The fund is constantly included in 2-6 investment rounds annually. The real fund results show that this VC is 45 percentage points more often commits exit comparing to other companies. The high activity for fund was in 2018. The common things for fund are deals in the range of 1 - 5 millions dollars.

This organization was formed by Geoff Simonett, Michael T. R. List. Besides them, we counted 1 critical employee of this fund in our database.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the GreenSky Capital, startups are often financed by Uni-Innovate Group, StartUp Health, SenseAI Ventures. The meaningful sponsors for the fund in investment in the same round are MaRS Investment Accelerator Fund, iGan Partners, Uni-Innovate Group. In the next rounds fund is usually obtained by LVL1 Group, Goddard Enterprises, Uni-Innovate Group.

Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most successful fund investment fields, there are Software, Information Technology. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Canada. Among the most popular portfolio startups of the fund, we may highlight RANK Software, AOMS Technologies Inc., Pyrowave.

Show more

Investor highlights

Industry focus
IoTB2B/EnterpriseLogisticsManufacturingMedtech Show 9 more
Stage focus
Seed
Geo focus
Canada

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
CDN 17000000
Fund raised date
2023-03-31

Analytics

Total investments
48
Lead investments
17
Exits
3
Rounds per year
3.00
Follow on index
0.40
Investments by industry
  • Software (16)
  • Health Care (11)
  • Biotechnology (10)
  • Medical (8)
  • Information Technology (7)
  • Show 70 more
Investments by region
  • Canada (44)
  • United States (3)
  • United Kingdom (1)
Peak activity year
2015

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
9
Avg. valuation at time of investment
14M
Group Appearance index
0.62
Avg. company exit year
6
Avg. multiplicator
3.86

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Mesosil 05 Jun 2024 Health Care, Medical Device, Advanced Materials Seed 1M Ontario, Old Toronto, Canada
Payment Rails 01 Sep 2018 Software, FinTech, Payments, Banking, Developer APIs Seed 795K Ontario, Old Toronto, Canada
Plasmonix 21 Jun 2011 Biotechnology, Genetics, Life Science Seed 1M United States, Maryland, Baltimore

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.